Karolinska Finds Macchiarini Guilty of Misconduct

The embattled thoracic surgeon is dealt another blow by his former employer, which is calling for the retraction of one of his papers on artificial esophagus research.

Written byBob Grant
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

YOUTUBE, ANNEWSPaolo Macchiarini, the Italian surgeon and artificial organ researcher accused of multiple counts of research misconduct, received more bad news this week when his former employer, Sweden’s Karolinska Institute (KI) found him guilty of misconduct. The institute then called for the retraction of the 2014 Nature paper marred by Macchiarini’s alleged malfeasance, which involved falsifying the results of a study on implanting artificial esophagi in rats. Three of the paper’s coauthors were also implicated.

“KI finds that Paolo Macchiarini and three of the co-authors had insight into and an overview of the process, either in its entirety or in large part, and are thus to be found guilty of scientific misconduct,” the institute said in a statement. “The remaining authors contributed in ways that are not judged to constitute misconduct, nor were they in a position to have had insight into or an overview of the whole project.”

Macchiarini initially made headlines when he was arrested and charged with fraud and attempted extortion in 2012, triggering retractions of some of his published work. But concerns about Macchiarini’s most recent line of research and clinical practice did not start swirling until 2014, after he was lauded as a pioneer on ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies